Kissei Stock - Analyst focus on pipeline as Japan listing holds steady
17.06.2026 - 21:14:35 | ad-hoc-news.de
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 21:12 JST. Details in the imprint.
Kissei Pharmaceutical (JP3212800001) is a midsize Japanese drug maker whose shares are listed on the Tokyo Stock Exchange. With no fresh company filings or major wire reports in the past 24 hours, today’s view centers on analyst expectations and the valuation of the stock.
All news and key data on Kissei Pharmaceutical stock
Kissei’s investor relations pages and our topic hub provide additional background on the company’s pipeline, strategy and share price performance.
How Kissei shares trade in Tokyo
Kissei shares trade on the Prime Market of the Tokyo Stock Exchange under the ticker 4547, with the stock price quoted in Japanese yen. A recent Tokyo Stock Exchange daily statistics sheet shows Kissei changing hands around JPY 3,960 on 06/16/2026.
On that day, the documented high was JPY 3,980 and the low JPY 3,935, indicating relatively narrow intraday fluctuations for the stock. Trading volume was modest, typical for a regional mid-cap pharmaceutical name in Japan’s market.
Analyst and consensus snapshot this Wednesday
Dedicated English-language analyst notes on Kissei remain sparse, reflecting the firm’s primary coverage by domestic Japanese brokerages rather than large global houses. Consensus data aggregators list only a handful of active recommendations on the stock, with mixed ratings and cautious commentary.
International investor attention has picked up slightly since 2023, when US-based Rigel Pharmaceuticals highlighted a licensing partnership that relies on Kissei as its Japanese partner. For many overseas market participants, Kissei’s role in this deal is one of the clearer entry points into the name.
The business behind Kissei Pharmaceutical
Kissei focuses on prescription drugs for specialty areas including urology, nephrology, and rare diseases, with research and development centered in Japan. Its portfolio spans treatments for kidney-related conditions, blood disorders and other chronic illnesses, often marketed domestically and through partners abroad.
Where the stock trades today
The shares of Kissei Pharmaceutical (JP3212800001) trade on the Tokyo Stock Exchange Prime Market at JPY 3,960.00 as of 06/16/2026, 15:00 JST.
Key facts on Kissei Pharmaceutical stock
- Company: Kissei Pharmaceutical Co., Ltd.
- ISIN: JP3212800001
- WKN: 8583
- Ticker: 4547
- Venue: TSE Prime Market
- Price (as of 06/16/2026, 15:00 JST): 3,960.00 JPY
- Market cap: 180,000,000,000 JPY (as of 06/16/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: Local Tokyo Stock Exchange indices
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
